Translational Neurosurgery
Translational Neurosurgery
Ahmad, Maleeha; Eltorai, Adam E.M.; Bakal, Jeffrey A.
Elsevier Science & Technology
12/2025
350
Mole
Inglês
9780323905091
15 a 20 dias
Descrição não disponível.
Section 1: Introduction
1. Translational Process
2. Scientific Method
Section 2: Pre-Clinical
4. What problem are you solving?
5. Types of interventions
6. Drug testing
7. Device discovery and prototyping
8. Diagnostic testing
9. Artificial Intelligence
Section 3: Statistical Principles
10. Basic statistical principles
11. Distributions
12. Hypotheses and error types
13. Power
14. Continuous variable analyses
15. Categorical variable analyses: Chi-square, fisher exact, Mantel hanzel
16. Analysis of variance
17. Correlation
18. Basic science statistics
19. Sample Size
20. Statistical Software
Section 4: Clinical: Study Types
21. Outcome measurements: What data is being collected and why?
22. Case series: Design, measures, classic example
23. Case-control study: Design, measures, classic example
24. Cross-section study: Design, measures, classic example
25. Longitudinal study: Design, measures, classic example
26. Meta-analysis: Design, measures, classic example
27. Qualitative methods and mixed methods
Section 5: Clinical Trials
28. Randomization and Multicentric Considerations in Clinical Trials
29. Nonrandomized Control
30. Historical Control
31. Study Types with Design, Measures, Classic Example
32. Blinding: Who and How?
33. Adaptive: Design, measures, classic example
34. Phase 0 Trials: Window of Opportunity
35. Registries, Phases of Clinical Trials, IDEAL Framework
Section 6: Regulatory Basics
36. FDA overview
37. IND
38. Devices
39. Radiation-emitting Electronic Products
40. Biologics
41. Combination Products
42. A Brief Overview of the FDAs Involvement in the Regulation of Dietary Supplements
43. Cosmetics
44. CMC and GxP
45. Non-US regulatory
46. Post-Market Drug Safety Monitoring
47. Post-Market Device Safety Monitoring
Section 7: Public Health
48. Public Health
49. Epidemiology
50. Factors
51. Good Questions
52. Population- and Environmental-specific Considerations
53. Healthcare Institutions and Systems
54. Public Health Institutions and Systems
55. Presenting Data
1. Translational Process
2. Scientific Method
Section 2: Pre-Clinical
4. What problem are you solving?
5. Types of interventions
6. Drug testing
7. Device discovery and prototyping
8. Diagnostic testing
9. Artificial Intelligence
Section 3: Statistical Principles
10. Basic statistical principles
11. Distributions
12. Hypotheses and error types
13. Power
14. Continuous variable analyses
15. Categorical variable analyses: Chi-square, fisher exact, Mantel hanzel
16. Analysis of variance
17. Correlation
18. Basic science statistics
19. Sample Size
20. Statistical Software
Section 4: Clinical: Study Types
21. Outcome measurements: What data is being collected and why?
22. Case series: Design, measures, classic example
23. Case-control study: Design, measures, classic example
24. Cross-section study: Design, measures, classic example
25. Longitudinal study: Design, measures, classic example
26. Meta-analysis: Design, measures, classic example
27. Qualitative methods and mixed methods
Section 5: Clinical Trials
28. Randomization and Multicentric Considerations in Clinical Trials
29. Nonrandomized Control
30. Historical Control
31. Study Types with Design, Measures, Classic Example
32. Blinding: Who and How?
33. Adaptive: Design, measures, classic example
34. Phase 0 Trials: Window of Opportunity
35. Registries, Phases of Clinical Trials, IDEAL Framework
Section 6: Regulatory Basics
36. FDA overview
37. IND
38. Devices
39. Radiation-emitting Electronic Products
40. Biologics
41. Combination Products
42. A Brief Overview of the FDAs Involvement in the Regulation of Dietary Supplements
43. Cosmetics
44. CMC and GxP
45. Non-US regulatory
46. Post-Market Drug Safety Monitoring
47. Post-Market Device Safety Monitoring
Section 7: Public Health
48. Public Health
49. Epidemiology
50. Factors
51. Good Questions
52. Population- and Environmental-specific Considerations
53. Healthcare Institutions and Systems
54. Public Health Institutions and Systems
55. Presenting Data
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
neurosurgery; translational neurosurgery; translational research; clinical research; statistical principles; case-control study; cohort study; clinical trials; reliability study; research regulatory
Section 1: Introduction
1. Translational Process
2. Scientific Method
Section 2: Pre-Clinical
4. What problem are you solving?
5. Types of interventions
6. Drug testing
7. Device discovery and prototyping
8. Diagnostic testing
9. Artificial Intelligence
Section 3: Statistical Principles
10. Basic statistical principles
11. Distributions
12. Hypotheses and error types
13. Power
14. Continuous variable analyses
15. Categorical variable analyses: Chi-square, fisher exact, Mantel hanzel
16. Analysis of variance
17. Correlation
18. Basic science statistics
19. Sample Size
20. Statistical Software
Section 4: Clinical: Study Types
21. Outcome measurements: What data is being collected and why?
22. Case series: Design, measures, classic example
23. Case-control study: Design, measures, classic example
24. Cross-section study: Design, measures, classic example
25. Longitudinal study: Design, measures, classic example
26. Meta-analysis: Design, measures, classic example
27. Qualitative methods and mixed methods
Section 5: Clinical Trials
28. Randomization and Multicentric Considerations in Clinical Trials
29. Nonrandomized Control
30. Historical Control
31. Study Types with Design, Measures, Classic Example
32. Blinding: Who and How?
33. Adaptive: Design, measures, classic example
34. Phase 0 Trials: Window of Opportunity
35. Registries, Phases of Clinical Trials, IDEAL Framework
Section 6: Regulatory Basics
36. FDA overview
37. IND
38. Devices
39. Radiation-emitting Electronic Products
40. Biologics
41. Combination Products
42. A Brief Overview of the FDAs Involvement in the Regulation of Dietary Supplements
43. Cosmetics
44. CMC and GxP
45. Non-US regulatory
46. Post-Market Drug Safety Monitoring
47. Post-Market Device Safety Monitoring
Section 7: Public Health
48. Public Health
49. Epidemiology
50. Factors
51. Good Questions
52. Population- and Environmental-specific Considerations
53. Healthcare Institutions and Systems
54. Public Health Institutions and Systems
55. Presenting Data
1. Translational Process
2. Scientific Method
Section 2: Pre-Clinical
4. What problem are you solving?
5. Types of interventions
6. Drug testing
7. Device discovery and prototyping
8. Diagnostic testing
9. Artificial Intelligence
Section 3: Statistical Principles
10. Basic statistical principles
11. Distributions
12. Hypotheses and error types
13. Power
14. Continuous variable analyses
15. Categorical variable analyses: Chi-square, fisher exact, Mantel hanzel
16. Analysis of variance
17. Correlation
18. Basic science statistics
19. Sample Size
20. Statistical Software
Section 4: Clinical: Study Types
21. Outcome measurements: What data is being collected and why?
22. Case series: Design, measures, classic example
23. Case-control study: Design, measures, classic example
24. Cross-section study: Design, measures, classic example
25. Longitudinal study: Design, measures, classic example
26. Meta-analysis: Design, measures, classic example
27. Qualitative methods and mixed methods
Section 5: Clinical Trials
28. Randomization and Multicentric Considerations in Clinical Trials
29. Nonrandomized Control
30. Historical Control
31. Study Types with Design, Measures, Classic Example
32. Blinding: Who and How?
33. Adaptive: Design, measures, classic example
34. Phase 0 Trials: Window of Opportunity
35. Registries, Phases of Clinical Trials, IDEAL Framework
Section 6: Regulatory Basics
36. FDA overview
37. IND
38. Devices
39. Radiation-emitting Electronic Products
40. Biologics
41. Combination Products
42. A Brief Overview of the FDAs Involvement in the Regulation of Dietary Supplements
43. Cosmetics
44. CMC and GxP
45. Non-US regulatory
46. Post-Market Drug Safety Monitoring
47. Post-Market Device Safety Monitoring
Section 7: Public Health
48. Public Health
49. Epidemiology
50. Factors
51. Good Questions
52. Population- and Environmental-specific Considerations
53. Healthcare Institutions and Systems
54. Public Health Institutions and Systems
55. Presenting Data
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.